Universitat Klinikum
- Address
- Department of Internal Medicine, Clinic for Internal Medicine II - Gastroenterology, Hepatology, Endo, 79106 Freiburg im Breisgau, France
Universität Klinikum - Viral Hepatitis Research Center
Universität Klinikum is a leading academic medical center with specialized expertise in viral hepatitis research and innovative immunotherapeutic approaches. The institution demonstrates particular strength in developing novel treatment strategies for chronic hepatitis B virus (HBV) infection, focusing on functional cure pathways beyond standard antiviral suppression.
- Chronic hepatitis B (CHB) functional cure strategies and immune modulation
- TLR8 agonist therapies and innate immune system activation
- Nucleos(t)ide analogue (NUC) discontinuation studies and treatment optimization
The center's research emphasizes translating proof-of-concept clinical trials into practical therapeutic advances for HBeAg-negative patients. Their work on educating the liver immune environment through targeted stimulation represents cutting-edge approaches to achieving sustained virological control and potentially eliminating the need for lifelong antiviral therapy in chronic hepatitis B patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universitat Klinikum
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Virological Efficacy of Entecavir, Selgantolimod, and Tenofovir Disoproxil in HBeAg-Negative Chronic Hepatitis B Patients | ANRS Maladies Infectieuses Emergentes | Phase II | Not Recruiting | Jan 2022 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Entecavir | 1 | Unknown | 2022-01-10 | 2022-01-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.